Wegrzyniak, Olivia https://orcid.org/0000-0001-9636-0390
Lechi, Francesco
Rokka, Johanna
Mitran, Bogdan
Zhang, Bo
Thelander, Ulrika
Löfblom, John
Frejd, Fredrik Y.
Korsgren, Olle
Perchiazzi, Gaetano
Eriksson, Jonas
Eriksson, Olof
Funding for this research was provided by:
Barndiabetesfonden
Diabetesfonden
Science for Life Laboratory
Vetenskapsrådet
Cancerfonden
EFDS/Lilly
ExoDiab
Stiftelsen Familjen Ernfors Fond
Alvar Gullstrand research
Swedish Heart and Lung Foundation
Uppsala University
Article History
Received: 8 May 2025
Accepted: 22 June 2025
First Online: 15 July 2025
Declarations
:
: All the performed procedures were in accordance with the ARRIVE guidelines for animal research. The animal experiments were ethically reviewed, authorized by the Animal Ethics Committee of the Swedish Animal Welfare Agency and carried out in accordance with the European Directive 2010/63/EEC and the institutional guidelines at Uppsala University (UFV 2007/724). All human biological sample donors in Sweden provide informed consent that their donated tissues may be entered into a BioBank and used in medical research, pending review and approval by a Regional Ethics Board (now Swedish Ethical Review Authority) of individual studies. The use of human lung tissues from Uppsala Biobank (registration #827) was approved by the Regional Ethics Board, Uppsala, Sweden (2024-00969) and were anonymized, collected, and treated according to local institutional and Swedish national rules and regulations.
: Not applicable.
: B.M. is an employee of Antaros Tracer AB. O.E. is an employee and minority shareholder of Antaros Tracer AB. O.K. is a minority shareholder of Antaros Tracer AB.